Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
Top Cited Papers
Open Access
- 13 December 2008
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 373 (9658) , 125-136
- https://doi.org/10.1016/s0140-6736(08)61766-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysisThe Lancet, 2008
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysisAnnals of Oncology, 2007
- Therapeutic role of lymph node resection in endometrioid corpus cancerCancer, 2006
- Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histologyGynecologic Oncology, 2006
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004
- Long-Term Survival of Intermediate Risk Endometrial Cancer (Stage IG3, IC, II) Treated with Full Lymphadenectomy and Brachytherapy without TeletherapyGynecologic Oncology, 2001
- Lymph Node Sampling and Survival in Endometrial CancerGynecologic Oncology, 1998
- Long-Term Outcomes of Therapeutic Pelvic Lymphadenectomy for Stage I Endometrial AdenocarcinomaGynecologic Oncology, 1998
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node SamplingGynecologic Oncology, 1995